Indian Firm Panacea Says Aiming to Make Covid-19 Vaccine
Indian Firm Panacea Says Aiming to Make Covid-19 Vaccine
The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year, Panacea said in a statement to stock exchanges.

Indian biotech firm Panacea Biotec Ltd said on Wednesday it would partner with US-based Refana Inc to make a potential vaccine for Covid-19.

The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year, Panacea said in a statement to stock exchanges.

Panacea's shares jumped 20 per cent in morning trading on India's National Stock Exchange after the news.

What's your reaction?

Comments

https://wapozavr.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!